Navigation Links
Mylan Applauds Obama Administration's Call to Create an "AIDS-Free Generation" Through Global Fight Against HIV/AIDS
Date:11/9/2011

PITTSBURGH, Nov. 9, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today applauded the Obama administration's call to action in the global fight against HIV/AIDS.

Mylan President Heather Bresch commented: "While the generics industry has made significant contributions toward making HIV/AIDS medicines more affordable, we believe the focus must now turn to expanding access to treatment for more people. As such, we're heartened that the Obama administration is embracing treatment as prevention and rallying global leaders to help end the global HIV/AIDS pandemic by making the creation of an 'AIDS-free generation' a policy priority. Achieving these objectives, as well as the goal of universal access set forth by the United Nations, will require close cooperation between governments, non-governmental organizations and the private sector."

Yesterday's speech by Secretary of State Hillary Clinton at the National Institutes of Health (NIH) comes at a critical time. Despite significant success in lowering infection rates, HIV/AIDS remains a leading cause of death globally and there are 7,000(1) new infections every day. Less than half of the estimated 15 million(2) people needing treatment receive it.

Recent scientific studies, including those conducted by NIH and the National Institute of Allergy and Infectious Diseases (NIAID), underscore the importance of early treatment. Evidence from these studies suggests that earlier initiation of treatment following testing and diagnosis may be the most effective means to prevent HIV transmission.

"With the 2012 International AIDS Society Conference taking place here in the U.S. in July 2012, the Obama administration has an ideal platform to take further steps to deliver on its commitments to addressing the global AIDS pandemic and make an 'AIDS-free generation' a reality. Mylan intends to do all it can to help by partnering with the administration, the U.N. and others to continue to expand access to high quality, affordable antiretrovirals used in the treatment of HIV/AIDS," concluded Bresch.

Approximately one-third of people in the developing world being treated for HIV/AIDS depend on a Mylan antiretroviral (ARV) product.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

(1) United Nations Program on HIV/AIDS
(2) World Health Organization


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan to Acquire Pfizer Respiratory Delivery Platform
2. Mylan Receives Approval for Generic Version of MS Contin® Tablets
3. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
4. Mylans Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents
5. Matrix Laboratories Completes Name Change to Mylan Laboratories
6. Mylan Announces Femcon® Fe Settlement Agreement
7. Mylan Announces Intention to Refinance Existing Secured Credit Facility
8. Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
9. Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs
10. Mylan Announces XELODA® Settlement and License Agreement
11. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... and Strategies - 2016" report to their offering. ... The latest research Autism ... pricing data and benchmarks in the global Autism Spectrum Disorder market. ... What are the key drugs marketed for Autism Spectrum Disorder ...
(Date:2/23/2017)... -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare ... ended 31 December 2016 compared with the previous corresponding period. A ... here . Highlights ... Earnings per share of 2.2 cents (Dec 2015: 1.2 ... $15.7m; up 11%) Profit before tax of $2.12m ...
(Date:2/23/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs Price ... in the global Oesophageal Cancer market. The research answers ... key drugs marketed for Oesophageal Cancer and their clinical attributes? How ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... ... disabilities, it is so critically important that we all are aware of our ... why Mediaplanet is proud to announce the launch of its newest edition of ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Yisrayl Hawkins, ... focuses on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement ... current generation. He explains that the Bible details the current times so plainly ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations to Head ... division on February 12th. Ms. Esparza qualified into this prestigious status after ... held in Las Vegas, Nevada. Frida is one of approximately 25 gymnasts in ...
(Date:2/23/2017)... FL (PRWEB) , ... February 23, 2017 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – will return to the La Gorce Country Club in Miami Beach to ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... in thought leadership , media relations, content marketing, social media management, corporate ... several clients already in the state and in nearby New Hampshire, Massachusetts and ...
Breaking Medicine News(10 mins):